PMV (Passy Muir Valve) Introduction + Sensory Priming The FEES shows mobile vocal folds bilaterally and bilateral LAR present — PMV candidacy is favorable. TASK DETAIL PMV trial Cuff must be fully deflated before PMV placement; confirm no air leak, adequate SpO₂ Duration target Begin 15–20 min; increase by 10 min each session toward 4–8 hrs/day Rationale PMV restores subglottic pressure → improves laryngeal sensation → reduces penetration/aspiration (O'Connor et al., Heart Lung 2019, PMID 30573194) explain how can i do this procedure aS AN SLP
"Passy Muir valve" tracheostomy dysphagia speech language pathology
Passy Muir valve PMV trial procedure SLP speech language pathologist step by step placement
"Passy Muir valve" swallowing sensation subglottic pressure
SLP PMV trial procedure steps cuff deflation placement monitoring
"speaking valve" tracheostomy aspiration laryngeal sensation

| Item | Action |
|---|---|
| Physician order | Ensure order is in for "speaking valve evaluation/trial" |
| Chart review | Trach brand, size, cuff type, vent status, recent secretion frequency |
| Trach tube type | Foam-cuffed trach = absolute contraindication for PMV |
| Glottic patency confirmed | FEES showing mobile VFs + bilateral LAR ✅ (your patient qualifies) |
| Equipment at bedside | PMV, pulse oximeter, suction (oral + tracheal), manual resuscitation bag |
| Pilot balloon label | Attach the PMV warning label to the pilot balloon line before you start |
| STOP Criteria | Action |
|---|---|
| SpO₂ drops below 93% | Remove PMV, suction, consider cuff re-inflation |
| HR increases >10 bpm above baseline | Remove PMV |
| RR increases significantly or WOB increases | Remove PMV |
| Patient reports significant discomfort | Remove PMV |
| Persistent, unrelieved coughing | May indicate upper airway obstruction — remove PMV |
| PMV pops off with cough | Suction, re-assess, replace securely |
| Contraindication | Reason |
|---|---|
| Foam-cuffed trach (e.g., Bivona) | Cuff cannot be fully deflated |
| Inability to tolerate cuff deflation | Exhalation pathway is obstructed |
| Severe upper airway obstruction | PMV would cause air trapping |
| Medical instability | Physiologic reserve too low |
| Severe aspiration risk | Relative — weigh risk/benefit; FEES helps stratify |
| Sleeping patient | Never leave PMV in during sleep |
| Concurrent HME use | Incompatible |
| Active aerosol/nebulizer treatment | Remove PMV first |
| Source | Finding |
|---|---|
| O'Connor et al., Heart & Lung 2019 [PMID 30573194] | Systematic review + meta-analysis: OR 0.12 for aspiration reduction with speaking valve in situ (p=0.003); also improved olfaction, secretion management, ventilator weaning |
| Cummings Otolaryngology | PMV aids swallowing and prevents aspiration by increasing subglottic pressure |
| Tintinalli's Emergency Medicine | PMV opens on inhalation, closes on exhalation; air directed through VCs; never use with cuffed tube |
Create a PMV trial protocol checklist PDF for SLP competency verification